Cytoreductive Nephrectomy in Metastatic Renal cell Cancer

Nosov, A.K.; Novik, A.V.; Vorobiev, A.V.; Samartseva, E.E.; Reva, S.A.; Baldueva, I.A.; Lushina, P.A.

Voprosy Onkologii 61(3): 494-498

2015


ISSN/ISBN: 0507-3758
PMID: 26242167
Document Number: 684725
The role of cytoreductive nephrectomy in the current era of targeted therapy remains unknown. Two prospective randomized phase III trials (CARMENA and SURTIME) are now opened to evaluate the efficacy of cytoreductive nephrectomy in patients with metastatic renal cell carcinoma. So far it is not well known who will and who will not benefit from such surgery.

Document emailed within 1 workday
Secure & encrypted payments